Publications en collaboration avec des chercheurs de Universidad de Salamanca (23)

2005

  1. Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients

    Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557

2004

  1. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients

    Acta Anaesthesiologica Scandinavica, Vol. 48, Núm. 8, pp. 1038-1048

  2. Techniques: New approaches to the delivery of biopharmaceuticals

    Trends in Pharmacological Sciences, Vol. 25, Núm. 7, pp. 382-387

2003

  1. Drug delivery in biotechnology: Present and future

    Current Opinion in Biotechnology, Vol. 14, Núm. 6, pp. 659-664

2002

  1. Prediction of unbound propofol concentrations in a diabetic population

    Therapeutic Drug Monitoring, Vol. 24, Núm. 6, pp. 689-695

  2. Sex specificity in methadone analgesia in the rat: A population pharmacokinetic and pharmacodynamic approach

    Pharmaceutical Research, Vol. 19, Núm. 6, pp. 858-867

1997

  1. Influence of route of administration and dosage form in the pharmacokinetic and bioavailability of salbutamol

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 22, Núm. 2, pp. 145-150

1996

  1. Correlation of 'in vitro' release and 'in vivo' absorption characteristics of four salbutamol sulphate formulations

    International Journal of Pharmaceutics, Vol. 139, Núm. 1-2, pp. 45-52

1995

  1. Distribution Kinetics of Roxithromycin in Isolated Lung of the Rat

    Pharmacy and Pharmacology Communications, Vol. 1, Núm. 7, pp. 315-319

  2. The Influence of Adrenalin on the Pharmacokinetics of Interpleurally Administered Lidocaine in Patients With Pancreatic Neoplasia

    The Journal of Clinical Pharmacology, Vol. 35, Núm. 4, pp. 426-431

1994

  1. Interspecies Scaling of Cimetidine–Theophylline Pharmacokinetic Interaction: Interspecies Scaling in Pharmacokinetic Interactions

    Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 11, Núm. 7, pp. 945-950

1992

  1. Pharmacokinetic‐pharmacodynamic modeling: Time‐dependent protein binding—an alternative interpretation of clockwise and counterclockwise hysteresis

    Journal of Pharmaceutical Sciences, Vol. 81, Núm. 3, pp. 232-236

1991

  1. Biotransformation kinetic of binifibrate and identification of its metabolites

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 5, pp. 172-177

  2. Influence of ecxipient in the release of ketamine from suppositories

    Bollettino Chimico Farmaceutico, Vol. 130, Núm. 2, pp. 52-54

  3. Pharmacokinetics and distribution of ketamine after extradural administration to dogs

    British Journal of Anaesthesia, Vol. 67, Núm. 3, pp. 310-316

  4. VALIDEZ DE LA INVESTIGACION PRECLINICA EN EL DESARROLLO DE NUEVOS ANTIBIOTICOS. ASPECTOS FARMACOCINETICOS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 9, Núm. 6, pp. 361-369

1988

  1. Choice of optimum pharmacokinetic model of orally administered paracetamol

    Biopharmaceutics and Drug Disposition, Vol. 9, pp. 389-396

1987

  1. Monitoring of serum levels of amitriptyline in overdose.

    Proceedings del III Congreso Europeo de Biofarmacia y Farmacocinética

  2. Pharmacokinetics and Clinical evaluation of ketamine administered by the IV andepidural routes

    International Journal of Clinical Pharmacology,Therapy and Toxicology, Vol. 25, pp. 77-80

1986

  1. Bioavailability of amoxapine in experimental animals

    Bolletino Chimico Farmaceutico, Vol. 135, pp. 307-311